Key statistics
As of last trade, Karolinska Development AB (0P3C:LSE) traded at 0.3015, 16.82% above the 52 week low of 0.2581 set on Dec 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 0.3015 |
| Low | 0.3015 |
| Bid | -- |
| Offer | -- |
| Previous close | 0.00 |
| Average volume | -- |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
Data delayed at least 20 minutes, as of Jan 19 2026 12:25 GMT.
More ▼
Announcements
- Karolinska Development’s portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement
- Karolinska Developments portföljbolag SVF Vaccines ingår avtal med Novakand Pharma om omvänt förvärv
- Karolinska Development AB (publ) announces the outcome of the rights issue and change of the company name to KDventures AB
- Karolinska Development AB (publ) offentliggör utfall i företrädesemissionen och genomför namnbyte till KDventures AB
- Karolinska Development AB receives additional guarantee commitments in ongoing rights issue
- Karolinska Development AB (publ) erhåller ytterligare garantiåtagande i pågående företrädesemission
- Karolinska Development’s portfolio company Dilafor signs binding term sheet with Exeltis for a license agreement regarding tafoxiparin
- Karolinska Developments portföljbolag Dilafor ingår bindande term sheet med Exeltis gällande licens avseende tafoxiparin
- The subscription period in Karolinska Development AB (publ)’s rights issue begins today
- Idag inleds teckningsperioden i Karolinska Development AB (publ):s företrädesemission
More ▼
